Liquidia (LQDA) Capital Expenditures (2020 - 2026)
Liquidia (LQDA) posted quarterly Capital Expenditures of $6.6 million for Q1 2026, up 42.43% year-over-year from $4.6 million in Q1 2025, and up 14735.56% quarter-over-quarter from -$45000.0 in Q4 2025.
Liquidia (LQDA) Capital Expenditures (2020 - 2026) Analysis & Trends
Liquidia's Capital Expenditures history runs 7 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 42.43% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $4.2 million (up 4.13% YoY), while the FY2025 annual figure was $2.3 million, up 972.86% from the prior year.
- Capital Expenditures for Q1 2026 stood at $6.6 million, up from -$45000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $6.6 million in Q1 2026, with the low at -$3.5 million in Q4 2024.
- The 5-year median for Capital Expenditures is $243000.0 (2023), against an average of $643000.0.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures soared 9250.0% in 2023, then plunged 2029.61% in 2025.
- Liquidia's Capital Expenditures stood at $491000.0 in 2022, then plunged by 58.04% to $206000.0 in 2023, then slumped by 1775.24% to -$3.5 million in 2024, then jumped by 98.7% to -$45000.0 in 2025, then surged by 14735.56% to $6.6 million in 2026.
- Business Quant data shows LQDA's Capital Expenditures at $6.6 million in Q1 2026, -$45000.0 in Q4 2025, and $911000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Liquidia | 6.34 Bn | 6.05 Bn | 160.92 Mn | 7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.48 Mn |
| Jun 30, 2026 | 7.48 Mn |
| Mar 31, 2026 | 6.59 Mn |
| Mar 31, 2026 | 6.59 Mn |
| Dec 31, 2025 | -45,000.00 |
| Dec 31, 2025 | -45,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Sep 30, 2025 | 911,000.00 |
| Jun 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | -3.24 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | -152,000.00 |
| Jun 30, 2024 | -152,000.00 |
| Mar 31, 2024 | 786,000.00 |
| Mar 31, 2024 | 786,000.00 |